A Leading Pharmaceutical Brand Increased Adherence 29% YoY with Swoop’s Patented Predictive Non-Adherence Audiences
With an increased incidence in substance use disorders (SUDs), a MAT therapy wanted to increase adherence within its patient population to drive positive patient outcomes. Leveraging Swoop’s patented predictive technology, the brand was able to accurately identify patients most likely to become non-adherent and activate them programmatically across premium inventory.
Advertising on CTV Increases HCP Appointments for Mental Health Drug by 20%
A pharmaceutical brand needed to connect with a limited patient population diagnosed with a sensitive conditionand their caregivers. Swoop utilized its privacy-safe real world health data to create a targetable niche segment for activation on CTV platforms.
Innovation and patients are at the heart of Swoop’s mission, and that commitment has been recognized with two wins in the 2025 PM360 Elite 100 awards. Co-founder and President of MyHealthTeam and Swoop Chief Patient Officer Eric Peacock and Swoop’s marketing team led by Chief Marketing Officer Marcella Milliet Sciorra have been recognized for their […]
Background Patients diagnosed with the rare disease of PAH must deal not only with the physical aspects of PAH, but also the mental health, social, and economic ramifications of this life-changing disease. Understanding the holistic impact of PAH on patients along with patient needs is crucial to enabling them to live more fulfilling lives.